⌘K

Kezar Life Sciences, Inc. (KZR)

$7.36 -1.06% $-0.08 Healthcare

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical trials for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b clinical trials in systemic lupus erythematosus and lupus nephritis. Its preclinical products include KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of KZR-261; and KZR-TBD for the treatment of oncology and immunology. The company was incorporated in 2015 and is based in South San Francisco, California.

Market cap

$53.71M

CEO

Mr. John Franklin Fowler

Full time employees

56.00

Headquarters

South San Francisco, CA

IPO Date

Jun 21, 2018

Price-to-earnings (PE) Ratio

-0.55

Earnings-per-share (EPS)

$-13.50

Cash ratio (TTM)

1.62

Current ratio (TTM)

9.58

Net profit margin (TTM)

-6,270.23%

PE ratio (TTM)

-5.50

PEG ratio (TTM)

0.14

Price-to-book ratio (TTM)

3.60

Price-to-sales ratio (TTM)

34.53

Quick ratio (TTM)

9.58

Return on assets (TTM)

-54.78%

Return on equity (TTM)

-54.50%

Similar stocks (15)

Revolution Medicines, Inc.

RVMD

$59.46 -1.88% $-1.14

Uptrend

Kymera Therapeutics, Inc.

KYMR

$50.22 -3.13% $-1.62

Uptrend

Keros Therapeutics, Inc.

KROS

$66.70 -2.13% $-1.45

Uptrend

Nurix Therapeutics, Inc.

NRIX

$26.69 -5.15% $-1.45

Uptrend

Cullinan Oncology, Inc.

CGEM

$16.02 -7.24% $-1.25

Downtrend

Larimar Therapeutics, Inc.

LRMR

$9.10 -2.05% $-0.19

Neutral

Monte Rosa Therapeutics, Inc.

GLUE

$9.13 -8.79% $-0.88

Uptrend

Foghorn Therapeutics Inc.

FHTX

$8.86 -4.53% $-0.42

Uptrend

Design Therapeutics, Inc.

DSGN

$6.91 4.54% $0.30

Uptrend

Lyell Immunopharma, Inc.

LYEL

$1.15 -4.96% $-0.06

Downtrend

Nkarta, Inc.

NKTX

$3.12 -7.96% $-0.27

Downtrend

Century Therapeutics, Inc.

IPSC

$1.41 -4.08% $-0.06

Downtrend

Werewolf Therapeutics, Inc.

HOWL

$2.15 -2.27% $-0.05

Downtrend

Ikena Oncology, Inc.

IKNA

$1.76 0.57% $0.01

Uptrend

Bolt Biotherapeutics, Inc.

BOLT

$0.64 0.91% $0.00

Downtrend

ETF Exposure (3)

Dimensional U.S. Small Cap ETF

DFAS

1.1038999999999999e-4%

$69.37 -1.28% $-0.90

Uptrend

Dimensional U.S. Targeted Value ETF

DFAT

1.1007e-4%

$59.32 -1.23% $-0.74

Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

5.291000000000001e-5%

$35.93 -0.53% $-0.19

Uptrend

Downtrend

Similar stocks (15)

Revolution Medicines, Inc.

RVMD

$59.46 -1.88% $-1.14

Uptrend

Kymera Therapeutics, Inc.

KYMR

$50.22 -3.13% $-1.62

Uptrend

Keros Therapeutics, Inc.

KROS

$66.70 -2.13% $-1.45

Uptrend

Nurix Therapeutics, Inc.

NRIX

$26.69 -5.15% $-1.45

Uptrend

Cullinan Oncology, Inc.

CGEM

$16.02 -7.24% $-1.25

Downtrend

Larimar Therapeutics, Inc.

LRMR

$9.10 -2.05% $-0.19

Neutral

Monte Rosa Therapeutics, Inc.

GLUE

$9.13 -8.79% $-0.88

Uptrend

Foghorn Therapeutics Inc.

FHTX

$8.86 -4.53% $-0.42

Uptrend

Design Therapeutics, Inc.

DSGN

$6.91 4.54% $0.30

Uptrend

Lyell Immunopharma, Inc.

LYEL

$1.15 -4.96% $-0.06

Downtrend

Nkarta, Inc.

NKTX

$3.12 -7.96% $-0.27

Downtrend

Century Therapeutics, Inc.

IPSC

$1.41 -4.08% $-0.06

Downtrend

Werewolf Therapeutics, Inc.

HOWL

$2.15 -2.27% $-0.05

Downtrend

Ikena Oncology, Inc.

IKNA

$1.76 0.57% $0.01

Uptrend

Bolt Biotherapeutics, Inc.

BOLT

$0.64 0.91% $0.00

Downtrend

ETF Exposure (3)

Dimensional U.S. Small Cap ETF

DFAS

1.1038999999999999e-4%

$69.37 -1.28% $-0.90

Uptrend

Dimensional U.S. Targeted Value ETF

DFAT

1.1007e-4%

$59.32 -1.23% $-0.74

Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

5.291000000000001e-5%

$35.93 -0.53% $-0.19

Uptrend